MedPath

The Minnesota Manual Dexterity Test As A Measure Of Hand Function in Multiple Sclerosis

Completed
Conditions
Multiple Sclerosis
Registration Number
NCT04721340
Lead Sponsor
Istanbul Aydın University
Brief Summary

The aim of the study is to report the results of manual dexterity using the Minnesota Manual Dexterity Test in people with Multiple Sclerosis.

Detailed Description

Upper limb can be affected even in early stage in people with Multiple Sclerosis (pwMS). Manual dexterity is important to maintain upper limb function and 9-Hole Peg Test (9HPT) is used as gold standard to assess dexterity in pwMS. There are no studies evaluating manual dexterity with the Minnesota Manual Dexterity Test (MMDT) in pwMS. This study aims to:

1. reporting the results of manual dexterity using the Minnesota Manual Dexterity Test and comparing the test results with healthy volunteers,

2. examining the relationship between MMDT and 9HPT, ABILHAND, grip strength, pinch strength, fatigue.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • (1) age 18-65;
  • (2) definitive diagnosis of MS according to McDonald criteria;
  • (3) ability to read and write in Turkish.
Exclusion Criteria
  • (1) acute attacks of MS (within 3 months);
  • (2) cognitive impairment (Mini Mental test result 24 points and below);
  • (3) having spasticity (3 and above according to Modified Ashworth Scale)
  • (4) any chronic disease other than MS;
  • (5) being addicted to alcohol or drugs,

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Minnesota Manual Dexterity Testbaseline (on the predetermined assessment day)

to assess manual dexterity, higher scores mean a worse outcome.

Secondary Outcome Measures
NameTimeMethod
9-Hole Peg Testbaseline (on the predetermined assessment day)

to assess manual dexterity. higher scores mean a worse outcome.

ABILHANDbaseline (on the predetermined assessment day)

to assess for performance of activity. score range 0-46 point, higher scores mean a better outcome.

Fatigue Severity Scalebaseline (on the predetermined assessment day)

to assess fatigue. score range 0-7 point, higher scores mean a worse outcome.

grip strengthbaseline (on the predetermined assessment day)

using hand dynamometer. higher scores mean a better outcome.

pinch strengthbaseline (on the predetermined assessment day)

using pinchmeter. higher scores mean a better outcome.

Trial Locations

Locations (1)

Istanbul Aydin University

🇹🇷

Istanbul, Küçükçekmece, Turkey

Istanbul Aydin University
🇹🇷Istanbul, Küçükçekmece, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.